A Risk Sciences International news item posted on December 12, 2022 and last updated on August 29, 2025

Working with international thought leaders in risk science, Risk Sciences International investigators contributed to the development of the evidenced-based risk assessment framework shown in the figure below.  The framework evolved from a workshop held at the University of Ottawa in December 2018, jointly organized by the McLaughlin Centre for Population Health Risk Assessment at the University of Ottawa and the Center for Alternatives to Animal Testing at Johns Hopkins University.  The workshop was attended by academic, governmental and industry specialists in risk science from Canada, the United States and Europe.  Further details on the new framework are included in a special issue of ALTEX, which includes the full workshop report and six companion papers prepared by individual specialists in risk science from North America and Europe.  

Preliminary evidence-based risk assessment framework
Preliminary
evidence-based
risk assessment
framework

Special Issue of ALTEX:

https://www.altex.org/index.php/altex/issue/view/special?

Experts related to this news item

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

More RSI News

IAI climate change report

April 12, 2022

The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and…

Quinolones and risk of acute liver failure

April 12, 2022

Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…

RSI launches Global Risk Census

March 1, 2022

Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be…

US FDA FAERS and quinolones

June 22, 2021

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised…